FI962550A - Deuterisoidut vaikuttavat aineet transdermaalisessa käyttötarkoituksessa - Google Patents

Deuterisoidut vaikuttavat aineet transdermaalisessa käyttötarkoituksessa Download PDF

Info

Publication number
FI962550A
FI962550A FI962550A FI962550A FI962550A FI 962550 A FI962550 A FI 962550A FI 962550 A FI962550 A FI 962550A FI 962550 A FI962550 A FI 962550A FI 962550 A FI962550 A FI 962550A
Authority
FI
Finland
Prior art keywords
pct
active substances
transdermal use
deuterated
sec
Prior art date
Application number
FI962550A
Other languages
English (en)
Swedish (sv)
Other versions
FI962550A0 (fi
Inventor
Hans-Rainer Hoffman
Thomas Hille
Andreas Koch
Rudolf Matusch
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of FI962550A0 publication Critical patent/FI962550A0/fi
Publication of FI962550A publication Critical patent/FI962550A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
FI962550A 1993-12-22 1996-06-19 Deuterisoidut vaikuttavat aineet transdermaalisessa käyttötarkoituksessa FI962550A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4343838A DE4343838C2 (de) 1993-12-22 1993-12-22 Deuteriertes Arzneimittel in transdermaler Applikation und Verfahren zu seiner Herstellung
PCT/EP1994/004047 WO1995017188A1 (de) 1993-12-22 1994-12-06 Deuterierte wirkstoffe in transdermaler applikation

Publications (2)

Publication Number Publication Date
FI962550A0 FI962550A0 (fi) 1996-06-19
FI962550A true FI962550A (fi) 1996-08-13

Family

ID=6505771

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962550A FI962550A (fi) 1993-12-22 1996-06-19 Deuterisoidut vaikuttavat aineet transdermaalisessa käyttötarkoituksessa

Country Status (21)

Country Link
US (1) US5895660A (fi)
EP (1) EP0737069B1 (fi)
JP (1) JP4451494B2 (fi)
KR (1) KR100371810B1 (fi)
AT (1) ATE237331T1 (fi)
AU (1) AU706814B2 (fi)
CA (1) CA2179778C (fi)
CZ (1) CZ180496A3 (fi)
DE (2) DE4343838C2 (fi)
DK (1) DK0737069T3 (fi)
ES (1) ES2197187T3 (fi)
FI (1) FI962550A (fi)
HU (1) HUT75700A (fi)
IL (1) IL112059A (fi)
MY (1) MY111718A (fi)
NO (1) NO962655L (fi)
NZ (1) NZ277036A (fi)
PL (1) PL178036B1 (fi)
SK (1) SK82596A3 (fi)
WO (1) WO1995017188A1 (fi)
ZA (1) ZA9410211B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4427690A1 (de) * 1994-08-04 1996-02-08 Bogdahn Ulrich Prof Deuterium enthaltende pharmazeutische Zusammensetzung als Zytostatikum oder Tumor-Therapeutikum
US6376531B1 (en) 1998-11-13 2002-04-23 Rupert Charles Bell Method of treatment using deuterium compounds
DE10129832A1 (de) * 2001-06-17 2003-07-10 Berolina Drug Dev Ab Svedala Deuterierte N- und alpha-substituierte Diphenylalkoxyessigsäureaminoalkylester sowie diese Verbindungen enthaltende Arzneimittel
US6872408B2 (en) * 2001-09-07 2005-03-29 Rupert C. Bell Method of treating bipolar disorders using deuterium-substituted carbonate
DE10214228A1 (de) * 2002-03-22 2003-10-02 Bdd Group Holding Ag Zug Deuterierte substitutierte Indole sowie diese Verbindungen enthaltende Arzneimittel
CN101528269A (zh) 2006-08-16 2009-09-09 奥斯拜客斯制药有限公司 阿片样物质止痛剂的制备和应用
DE102007031397A1 (de) * 2007-07-05 2009-01-08 D2O Bioscience Group Ltd. Verwendung von Deuteriumoxid zur Behandlung von Virus-basierten Erkrankungen der Haut
BRPI0916769A2 (pt) * 2008-07-15 2017-09-26 Theracos Inc derivados de benzilbenzeno deuterados e métodos de uso
CA2732508C (en) 2008-08-11 2016-03-15 Nektar Therapeutics Multi-arm polymeric alkanoate conjugates
US8658236B2 (en) 2009-08-21 2014-02-25 Deuteria Beverages, Llc Alcoholic compositions having a lowered risk of acetaldehydemia
US20130331443A1 (en) 2010-12-22 2013-12-12 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
WO2012088433A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Deuterated and/or fluorinated taxane derivatives
US10894087B2 (en) 2010-12-22 2021-01-19 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
US8778223B2 (en) 2011-05-24 2014-07-15 Lc Vision, Llc Liquid crystals having cyclohexyl core structures and fluorinated tails

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
SE426011B (sv) * 1976-01-30 1982-12-06 Sixten Abrahamsson Anvendning av en helt eller partiellt deutererad acyklisk, enbasisk karboxyylayra for att skydda ett material i form av levande vexter, utsede och tre mot skadliga svampar
US4475585A (en) * 1981-06-11 1984-10-09 Snyder General Corporation Air conditioning and heat pump cabinets with removable coil guards
US4529600A (en) * 1982-09-09 1985-07-16 Sri International Pentadeuterioretinoids
DE3315272C2 (de) * 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
US4898855A (en) * 1987-09-14 1990-02-06 Hoffman-La Roche Inc. Deuterated analogs of 1,25-dihydroxycholecalciferol
US4876260A (en) * 1987-10-28 1989-10-24 State Of Israel, Israel Institute Of Biological Research Oxathiolanes
US5075337A (en) * 1989-07-26 1991-12-24 G. D. Searle & Co. Alpha-deuterated 2-alkylaminoacetamide derivatives having reduced toxicity for treatment of CNS disorders
GB9201275D0 (en) * 1992-01-21 1992-03-11 Norsk Hydro As New compounds

Also Published As

Publication number Publication date
CA2179778C (en) 2005-09-06
ZA9410211B (en) 1996-02-06
DK0737069T3 (da) 2003-07-28
NO962655D0 (no) 1996-06-21
CA2179778A1 (en) 1995-06-29
FI962550A0 (fi) 1996-06-19
KR100371810B1 (ko) 2003-07-22
MY111718A (en) 2000-11-30
JPH09506874A (ja) 1997-07-08
ES2197187T3 (es) 2004-01-01
DE4343838A1 (de) 1995-06-29
HUT75700A (en) 1997-05-28
CZ180496A3 (en) 1997-02-12
NO962655L (no) 1996-08-20
PL315127A1 (en) 1996-10-14
DE59410275D1 (de) 2003-05-22
EP0737069B1 (de) 2003-04-16
AU706814B2 (en) 1999-06-24
WO1995017188A1 (de) 1995-06-29
ATE237331T1 (de) 2003-05-15
JP4451494B2 (ja) 2010-04-14
SK82596A3 (en) 1997-03-05
HU9601684D0 (en) 1996-08-28
DE4343838C2 (de) 1998-07-09
NZ277036A (en) 1998-06-26
EP0737069A1 (de) 1996-10-16
IL112059A (en) 1999-06-20
AU1191795A (en) 1995-07-10
IL112059A0 (en) 1995-03-15
US5895660A (en) 1999-04-20
PL178036B1 (pl) 2000-02-29

Similar Documents

Publication Publication Date Title
AR003989A1 (es) Composicion cosmetica o farmaceutica y procedimiento de tratamiento cosmetico, excluido tdo tratamiento terapeutico que utiliza la composicion cosmetica.
PT99513A (pt) Processo para a preparacao de composicoes farmaceuticas contendo profarmacos de morfina para administracao topica por via transdermica
ES2183186T3 (es) Composiciones cosmeticas en polvo que contienen elastomeros de silicona.
BR9406893A (pt) Emprego de nona- e decapeptideos para a preparação de um medicamento para o combate da aids
FI962550A (fi) Deuterisoidut vaikuttavat aineet transdermaalisessa käyttötarkoituksessa
ATE234274T1 (de) Derivate des adamantan
ES2140658T3 (es) Sistemas terapeuticos transdermicos que contienen esteroides sexuales.
FI953442A (fi) Gonadotropiinia sisältäviä pakastekuivattuja pallosia
AR006401A1 (es) Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.
DK0561846T3 (da) 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning
ES491340A0 (es) Procedimiento para la obtencion de 11-alquilen-morfantridi- nas 6-sustituidas
BR9508021A (pt) Composição farmacêutica para o tratamento de distúrbios esquizofrênicos, uso de um agente imunossupressor, e, processo de tratamento de um paciente esquizofrênico
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
ES2151922T3 (es) Uso de aspirina para la fabricacion de un medicamento para mejorar la perfusion sanguinea en el utero.
BR9407340A (pt) Meio hormonal para tratamento de acne
MX9302986A (es) Medicamento que contiene metrifonato y procedimiento para su preparacion
AR010336A1 (es) Uso de 17 alfa-dihidroequilenina o una sal farmaceuticamente aceptable del ester 17 alfa-dihidroequilenina-3-sulfato para la manufactura de un medicamentoutil para inhibir o tratar patologias inducidas por los radicales libres y una composicion farmaceutica.
ZA9427B (en) Use of riluzole for promoting restoration following radiation
IT1257479B (it) Derivati prostaglandinici aventi effetti radioprotettivi
BR9815993A (pt) Comprimido de liberação cronometrada compreendendo naproxen e pseudoefedrina
MX9800697A (es) Uso de glicosidos de calendula para el tratamiento de psoriasis.
ATE221068T1 (de) Anellierte beta-carboline
MX9709684A (es) Uso de derivados de vitamina d4 para tratamiento de trastornos de la piel.
MX9605916A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en para, composiciones farmaceuticos y cosmeticas que los contienen y utilizaciones.
UA26886C2 (uk) Солі 1,3-діарил-4,5-поліметилеhімідазолію, що виявляють аhальгезуючу активhість